Latest Australian Healthcare Funding News

Page 1 of 1

Garvan Institute Secures $3M Grant to Test Syntara’s Drug in Pancreatic Cancer Trial

The Garvan Institute has won a $3 million MRFF grant to conduct pivotal pancreatic cancer studies, including one evaluating Syntara’s amsulostat combined with chemotherapy. Recruitment is slated to begin mid-2026 across major NSW cancer centres.

Ada Torres

21 Jan 2026

Top